Diabetes Drug Discovery: hIAPP1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets

Diabetes Drug Discovery: hIAPP1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets

Human islet amyloid peptide (hIAPP1–37) aggregation is an early step in Diabetes Mellitus. We aimed to evaluate a family of pharmaco-chaperones to act as modulators that provide dynamic interventions and the multi-target capacity (native state, cytotoxic oligomers, protofilaments and fibrils of hIAP...

Full description

Bibliographic Details
Main Authors:	Isaac Fernández-Gómez, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Guadalupe Domínguez, Reyna Lara-Martínez, Nelly F. Altamirano-Bustamante, Luis Felipe Jiménez-García, Karina Pasten-Hidalgo, Rosa Angélica Castillo-Rodríguez, Perla Altamirano, Suchitil Rivera Marrero, Cristina Revilla-Monsalve, Peter Valdés-Sosa, Fabio Salamanca-Gómez, Eulalia Garrido-Magaña, Chryslaine Rodríguez-Tanty, Myriam M. Altamirano-Bustamante
Format:	Article
Language:	English
Published:	MDPI AG 2018-03-01
Series:	Molecules
Subjects:	IAPP diabetes mellitus pharmacological chaperones amyloid structures conformational diseases drug discovery
Online Access:	http://www.mdpi.com/1420-3049/23/3/686

Similar Items

The Effect of Calcium Ions on hIAPP Channel Activity: Possible Implications in T2DM
by: Daniela Meleleo, et al.
Published: (2023-11-01)

β-Hairpin Peptide Mimics Decrease Human Islet Amyloid Polypeptide (hIAPP) Aggregation
by: Jacopo Lesma, et al.
Published: (2021-09-01)

Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model
by: Hyeon Ji Yeo, et al.
Published: (2023-06-01)

Melatonin Inhibits hIAPP Oligomerization by Preventing β-Sheet and Hydrogen Bond Formation of the Amyloidogenic Region Revealed by Replica-Exchange Molecular Dynamics Simulation
by: Gang Wang, et al.
Published: (2022-09-01)

Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetes.
by: Nelly F Altamirano-Bustamante, et al.
Published: (2020-01-01)

Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)

Urolithin B: Two-way attack on IAPP proteotoxicity with implications for diabetes
by: Ana F. Raimundo, et al.
Published: (2022-12-01)

Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
by: Andisheh Abedini, et al.
Published: (2016-05-01)

Identificación y caracterización in silico de la zona de interación entre el péptido beta-amiloide y compuestos derivados del naftaleno
by: Alberto Bencomo-Martínez, et al.
Published: (2012-12-01)

SORLA mediates endocytic uptake of proIAPP and protects against islet amyloid deposition
by: Alexis Z.L. Shih, et al.
Published: (2022-11-01)

Effect of DNA Origami Nanostructures on hIAPP Aggregation
by: Marcel Hanke, et al.
Published: (2020-11-01)

Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells
by: Camilla Krizhanovskii, et al.
Published: (2017-07-01)

Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures.
by: Marquiza Sablón-Carrazana, et al.
Published: (2015-01-01)

Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide
by: Tatyana Gurlo, et al.
Published: (2023-02-01)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
by: Adriana Sevcuka, et al.
Published: (2022-04-01)

Proteins behaving badly: the role of (hIAPP) in type 2 diabetes
by: Terry, Cassandra, et al.
Published: (2023)

Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus
by: Sevcuka, Adriana, et al.
Published: (2022)

Effect of Terminal Modifications on the Adsorption and Assembly of hIAPP(20–29)
by: Roozbeh Hajiraissi, et al.
Published: (2019-02-01)

Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate
by: Diana C Rodriguez Camargo, et al.
Published: (2017-11-01)

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
by: Anne-Cathrine S. Vogt, et al.
Published: (2021-11-01)

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
by: Yong Xu, et al.
Published: (2022-02-01)

Nanoscale Surface Topography Modulates hIAPP Aggregation Pathways at Solid–Liquid Interfaces
by: Marcel Hanke, et al.
Published: (2021-05-01)

Procedure to obtain the 3´,5´-di-O-acetyl-5-formyl- 2´-deoxyuridine
by: Marquiza Sablón-Carrazana, et al.
Published: (2007-12-01)

Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity
by: Pascal Krotee, et al.
Published: (2017-01-01)

Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective
by: Hassan, Shahab, et al.
Published: (2022)

Síntesis química del fármaco antiviral d4T
by: Marquiza Sablón, et al.
Published: (2003-05-01)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
by: Qin-Yu Meng, et al.
Published: (2020-03-01)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes
by: Angelina S. Bortoletto, et al.
Published: (2022-12-01)

High-Fat Diet Increases Amylin Accumulation in the Hippocampus and Accelerates Brain Aging in hIAPP Transgenic Mice
by: Xiao-Xia Xi, et al.
Published: (2019-08-01)

Magnetic Nanoparticles Conjugated to Amylovis<sup>®</sup> as Contrast Agents, Synthesis and In Silico Evaluation
by: Claudia González, et al.
Published: (2022-11-01)

Obtención de nuevos derivados de naftaleno como potenciales fármacos para la enfermedad de Alzheimer
by: Marquiza Sablón Carrazana
Published: (2014-12-01)

Pentapeptide Protects INS-1 Cells From hIAPP-Mediated Apoptosis by Enhancing Autophagy Through mTOR Pathway
by: Jianzhen Lin, et al.
Published: (2019-08-01)

Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo
by: Xiao-Dan Mo, et al.
Published: (2018-03-01)

Bayesian Total Internal Reflection Fluorescence Correlation Spectroscopy Reveals hIAPP-Induced Plasma Membrane Domain Organization in Live Cells
by: Guo, Syuan-Ming, et al.
Published: (2014)

Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction
by: Júlia Rodríguez-Comas, et al.
Published: (2020-07-01)

Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming
by: Yuanzheng Yang, et al.
Published: (2022-09-01)

Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
by: Ana F. Raimundo, et al.
Published: (2020-03-01)

Mechanistic Insights into the Polymorphic Associations and Cross-Seeding of Aβ and hIAPP in the Presence of Histidine Tautomerism: An All-Atom Molecular Dynamic Study
by: Abbas Salimi, et al.
Published: (2022-02-01)

Síntesis de nuevos derivados del naftaleno
by: Suchitil,Marquiza,Rosa,Rafaela. María. Rivera,Sablón,López,Pérez
Published: (2011-09-01)

Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
by: Yoshimitsu Kiriyama, et al.
Published: (2018-08-01)